New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Gracell Biotechnologies Inc.
GRCL
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

990M

Biotechnology

10.25USD
Shape0.01 ( 0.05%)
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

335%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 14, 2024
1W % 1M % 3M % 1Y 313.31 %

Key Metrics

Shape
  • Market Cap

    989.87M


  • Shares Outstanding

    96.57M


  • Share in Float

    165.04M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    10.25


  • Average Volume

    1.46M


  • Beta

    -0.345


  • Range

    1.4-10.435


  • Industry

    Biotechnology


  • Website

    https://www.gracellbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

3.76x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-1.0

EPS

How GRCL compares to sector?

P/E Ratio

Relative Strength

Shape

GRCL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$920K

ShapeNaN%

2025-Revenue

$0.53

Shape57%

2025-EPS

$552K

ShapeNaN%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

initialise

Previous: Not converted

2022-09-22

Now: Negative

Cantor Fitzgerald

initialise

Previous: Not converted

2022-06-01

Now: Overweight

BTIG

initialise

Previous: Not converted

2022-04-04

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-0.30
vs -0.16

Q1.22

arrow
arrow

N/A

-0.37
vs -0.25

Q2.22

arrow
arrow

N/A

-0.32
vs -0.22

Q3.22

arrow
arrow

N/A

-0.36
vs -0.30

Q4.22

arrow
arrow

N/A

-0.30
vs -0.30

Q1.23

arrow
arrow

N/A

-0.35
vs -0.37

Q2.23

arrow
arrow

N/A

-0.30
vs -0.32

Q3.23

arrow
arrow

N/A

-0.10
vs -0.36

Q4.23

arrow
arrow

N/A

-0.27
vs -0.30

Q1.24

arrow
arrow

+550%

1.58
vs -0.35

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

NA

NA  vs NA

Q3.21

arrow
arrow

NA

366K  vs NA

Q4.21

arrow
arrow

NA

NA  vs NA

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

-100%

NA  vs 366K

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

-7%

-0.07
vs -0.07

Q1.22

arrow
arrow

-9%

-0.09
vs -0.07

Q2.22

arrow
arrow

-9%

-0.09
vs -0.09

Q3.22

arrow
arrow

-11%

-0.11
vs -0.09

Q4.22

arrow
arrow

-9%

-0.09
vs -0.11

Q1.23

arrow
arrow

-13%

-0.13
vs -0.09

Q2.23

arrow
arrow

-13%

-0.13
vs -0.13

Q3.23

arrow
arrow

-4%

-0.04
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

32

32
vs 35

-9%

Q2.22

arrow
arrow

32

32
vs 32

NA

Q3.22

arrow
arrow

30

30
vs 32

-6%

Q4.22

arrow
arrow

31

31
vs 30

3%

Q1.23

arrow
arrow

31

31
vs 31

NA

Q2.23

arrow
arrow

35

35
vs 31

13%

Q3.23

arrow
arrow

43

43
vs 35

23%

Q4.23

arrow
arrow

69

69
vs 43

60%

Earnings Growth

Latest News